Manufacturer record
Arya Pharmaceuticals: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Arya Pharmaceuticals (Madhya Pradesh) was declared Not of Standard Quality in September 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: L-2401, Loperamide Hydrochloride Tablets I.P. 2 mg (LOMJAN) (exp Dec 2025). RDTL Guwahati (CDSCO lab) found it not of standard quality: Dissolution and Assay/ Content of Loperamide Hydrochloride and Description. Listed in the September 2024 alert.
Records by type
1 record linked to Arya Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Loperamide Hydrochloride Tablets I.P. 2 mg (LOMJAN) | Batch L-2401Mfg Jan 2024 · Exp Dec 2025 | Dissolution and Assay/ Content of Loperamide Hydrochloride and DescriptionAssay | RDTL GuwahatiCDSCO lab | Sep 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.